We are live on ! Find out more
VTAE

VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE

Delisted

VTAE was delisted on the 24th of October, 2016.

Back to rankings

52 hedge funds and large institutions have $138M invested in VITAE PHARMACEUTICALS INC COMMON STOCK in 2015 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

220% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 5

180% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 10

53% more funds holding

Funds holding: 34 → 52 (+18)

14% more capital invested

Capital invested by funds: $120M → $138M (+$17.4M)

Holders
52
Holders Change
+18
Holders Change %
+52.94%
% of All Funds
1.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
16
Reduced
5
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$15.9M
2
BI
BVF Inc
California
+$11.1M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$5.4M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.92M
5
GTC
Ghost Tree Capital
New York
+$4.05M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$3.44M
2
EI
EAM Investors
California
-$1.31M
3
ARTA
A.R.T. Advisors
New York
-$684K
4
Citadel Advisors
Citadel Advisors
Florida
-$451K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$344K
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
26
T. Rowe Price Associates
Maryland
$379K +$436K +32,332 New
PC
27
Polar Capital
United Kingdom
$260K +$300K +22,238 New
BIM
28
BlackRock Investment Management
Delaware
$227K +$261K +19,349 New
TCIM
29
TIAA CREF Investment Management
New York
$197K +$69.8K +5,174 +44%
Charles Schwab
30
Charles Schwab
California
$170K +$11K +812 +6%
HLA
31
Hamilton Lane Advisors
Pennsylvania
$159K +$183K +13,537 New
Bessemer Group
32
Bessemer Group
New Jersey
$152K +$175K +12,980 New
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$141K +$21.6K +1,600 +15%
UOTTAIMCU
34
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$130K +$150K +11,100 New
TA
35
Teachers Advisors
New York
$100K +$47.2K +3,499 +69%
BG
36
BlackRock Group
United Kingdom
$95K +$110K +8,122 New
Morgan Stanley
37
Morgan Stanley
New York
$73K -$245K -18,182 -74%
NFA
38
Nationwide Fund Advisors
Ohio
$57K +$10.5K +776 +19%
TC
39
Travelers Companies
Minnesota
$48K +$54.7K +4,057 New
AIG
40
American International Group
New York
$41.3K – – –
Acadian Asset Management
41
Acadian Asset Management
Massachusetts
$36K +$41.4K +3,071 New
Wells Fargo
42
Wells Fargo
California
$25K +$28.6K +2,119 New
SO
43
STRS Ohio
Ohio
$22K – – –
TI
44
Turner Investments
Pennsylvania
$18K +$20.2K +1,500 New
BJ
45
BlackRock Japan
Japan
$18K +$20.8K +1,544 New
CSS
46
Cubist Systematic Strategies
Connecticut
$14K +$16.2K +1,200 New
Citigroup
47
Citigroup
New York
$4K -$9.47K -702 -66%
Barclays
48
Barclays
United Kingdom
$2K -$3.47K -257 -56%
BlackRock
49
BlackRock
New York
$2K +$2.74K +203 New
BNP Paribas Financial Markets
50
BNP Paribas Financial Markets
France
$1.69K +$1.94K +144 New
1
2
3

VTAE Hedge Fund Activity: Q1 2015 in Review

52 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) for Q1 2015, worth a combined $138M — up 14% from $120M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new VTAE positions and 10 closed out — a net gain of 18 holders — while 16 added to existing stakes and 5 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $15.9M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $3.44M sold.

  • 52 institutional investors held VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) as of Q1 2015, up from 34 in Q4 2014.
  • Funds reported $138M of VITAE PHARMACEUTICALS INC COMMON STOCK stock for Q1 2015, up 14% quarter-over-quarter.
  • 28 funds opened new VITAE PHARMACEUTICALS INC COMMON STOCK positions in Q1 2015 and 10 closed out, a net change of +18 holders.
  • The largest VITAE PHARMACEUTICALS INC COMMON STOCK buyer in Q1 2015 was Fidelity Investments, an estimated $15.9M added.
  • The largest VITAE PHARMACEUTICALS INC COMMON STOCK seller in Q1 2015 was EcoR1 Capital, an estimated $3.44M sold.

Based on aggregated 13F filings for Q1 2015.